Kanyr Pharma
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
900 Rue Étienne-marchand Boucherville, M...Website
www.kanyrpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Kanyr Pharma
Kanyr was incorporated in May 2013. Kanyr Pharma Inc. is a privately held biotechnology company working to bring a small molecule inhibitor to phase 1B/2 clinical trial of two closely linked PTPs, PTPN1 (PTP1B) and PTPN2 (TC-PTP). This orally available compound KQ791 improves immune response against different solid cancers, alone or in synergy with checkpoint inhibitors.Explore more
Popular SearchesKanyr PharmaKanyr Pharma IncKaneq Pharma IncKanyrpharmaSIC Code 87,873NAICS Code 54,541Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kanyr Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Kanyr Pharma has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Kanyr Pharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Kanyr Pharma
Kanyr Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Kanyr Pharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Kanyr Pharma launches new products
Funding: Get notified immidiatlly once Kanyr Pharma has new funding data
Check out if Kanyr Pharma is spiking on competitors!
Recommended Actions
Find VP level buyers at Kanyr Pharma
Find more new buyers
Compare Similar Companies to Kanyr Pharma
Compare insights from companies similar to Kanyr Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kanyr Pharma
<$5M
11-50
Private
-
2013
N/A
Company Profile Activity
Activity Insights
Kanyr Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kanyr Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kanyr Pharma.
Kanyr Pharma Tech Stack
A closer look at the technologies used by Kanyr Pharma
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Kanyr Pharma
Sign Up For FreeTo access detailed company insights
Kanyr was incorporated in May 2013. Kanyr Pharma Inc. is a privately held biotechnology company working to bring a small molecule inhibitor to phase 1B/2 clinical trial of two closely linked PTPs, PTPN1 (PTP1B) and PTPN2 (TC-PTP). This orally available compound KQ791 improves immune response against different solid cancers, alone or in synergy with... Read More
